FI942793A - Fuusioituneen bisyklisen renkaan sisältäviä yhdisteitä ja menetelmiä niiden valmistamiseksi - Google Patents
Fuusioituneen bisyklisen renkaan sisältäviä yhdisteitä ja menetelmiä niiden valmistamiseksi Download PDFInfo
- Publication number
- FI942793A FI942793A FI942793A FI942793A FI942793A FI 942793 A FI942793 A FI 942793A FI 942793 A FI942793 A FI 942793A FI 942793 A FI942793 A FI 942793A FI 942793 A FI942793 A FI 942793A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- processes
- compounds containing
- bicyclic ring
- fused bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7797893A | 1993-06-15 | 1993-06-15 | |
US7797893 | 1993-06-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI942793A0 FI942793A0 (fi) | 1994-06-13 |
FI942793A true FI942793A (fi) | 1994-12-16 |
FI106464B FI106464B (fi) | 2001-02-15 |
Family
ID=22141128
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI942793A FI106464B (fi) | 1993-06-15 | 1994-06-13 | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridotiatsepiini-, pyrido-oksatsepiini-, pyridotiatsiini-, pyrrolo-oksatsepiini- ja pyrrolotiatsepiinijohdannaisten valmistamiseksi |
FI20000814A FI111947B (fi) | 1993-06-15 | 2000-04-06 | Menetelmä uusien terapeuttisesti käyttökelpoisten 5-okso-[1,4]oksatsino[3,4-b][1,3]oksatsepiini- ja -tiatsepiini-7-karboksyylihappojohdannaisten valmistamiseksi |
FI20000815A FI111950B (fi) | 1993-06-15 | 2000-04-06 | 5-okso-7H-pyrido[2,1-b][1,3]tiatsepiini-, 4-okso-2H,6H-pyrido[2,1-b][1,3]tiatsiini- ja 5-oksopyrrolo[2,1-b][1,3]tiatsepiinijohdannaisia |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20000814A FI111947B (fi) | 1993-06-15 | 2000-04-06 | Menetelmä uusien terapeuttisesti käyttökelpoisten 5-okso-[1,4]oksatsino[3,4-b][1,3]oksatsepiini- ja -tiatsepiini-7-karboksyylihappojohdannaisten valmistamiseksi |
FI20000815A FI111950B (fi) | 1993-06-15 | 2000-04-06 | 5-okso-7H-pyrido[2,1-b][1,3]tiatsepiini-, 4-okso-2H,6H-pyrido[2,1-b][1,3]tiatsiini- ja 5-oksopyrrolo[2,1-b][1,3]tiatsepiinijohdannaisia |
Country Status (38)
Country | Link |
---|---|
US (5) | US5508272A (fi) |
EP (1) | EP0629627B1 (fi) |
JP (1) | JP3569550B2 (fi) |
KR (1) | KR100395604B1 (fi) |
CN (1) | CN1046525C (fi) |
AT (1) | ATE266032T1 (fi) |
AU (1) | AU672899B2 (fi) |
BG (1) | BG62139B1 (fi) |
BR (1) | BR1100970A (fi) |
CA (1) | CA2124375C (fi) |
CY (1) | CY2492B1 (fi) |
CZ (1) | CZ289488B6 (fi) |
DE (1) | DE69433752T2 (fi) |
DK (1) | DK0629627T3 (fi) |
EE (1) | EE03178B1 (fi) |
EG (1) | EG20537A (fi) |
ES (1) | ES2219644T3 (fi) |
FI (3) | FI106464B (fi) |
GE (1) | GEP19981301B (fi) |
HK (1) | HK1001814A1 (fi) |
HU (1) | HU216791B (fi) |
IL (2) | IL109924A (fi) |
LT (1) | LT3626B (fi) |
LV (1) | LV10622B (fi) |
MY (1) | MY123673A (fi) |
NO (1) | NO306405B1 (fi) |
NZ (1) | NZ260736A (fi) |
PH (1) | PH30830A (fi) |
PL (1) | PL178469B1 (fi) |
PT (1) | PT629627E (fi) |
RO (1) | RO112870B1 (fi) |
RU (1) | RU2125056C1 (fi) |
SG (1) | SG46510A1 (fi) |
SK (1) | SK282529B6 (fi) |
TW (1) | TW329423B (fi) |
UA (1) | UA39924C2 (fi) |
UY (1) | UY23787A1 (fi) |
ZA (1) | ZA944163B (fi) |
Families Citing this family (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
US5504080A (en) * | 1992-10-28 | 1996-04-02 | Bristol-Myers Squibb Co. | Benzo-fused lactams |
US5654294A (en) * | 1993-05-13 | 1997-08-05 | Bristol-Myers Squibb | Spiro lactam dual action inhibitors |
WO1994028901A1 (fr) * | 1993-06-11 | 1994-12-22 | Eisai Co., Ltd. | Derive aminoacide |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
US5525723A (en) * | 1993-11-18 | 1996-06-11 | Bristol-Myers Squibb Co. | Compounds containing a fused multiple ring lactam |
US5587375A (en) * | 1995-02-17 | 1996-12-24 | Bristol-Myers Squibb Company | Azepinone compounds useful in the inhibition of ACE and NEP |
US5877313A (en) | 1995-05-17 | 1999-03-02 | Bristol-Myers Squibb | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
US5650408A (en) * | 1995-06-07 | 1997-07-22 | Karanewsky; Donald S. | Thiazolo benzazepine containing dual action inhibitors |
US5635504A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Co. | Diazepine containing dual action inhibitors |
US6777550B1 (en) | 1996-04-12 | 2004-08-17 | Bristol-Myers Squibb Company | N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors |
PL335839A1 (en) | 1997-03-14 | 2000-05-22 | Basf Ag | Cycloalkylalkane carboxamides as well as their production and application |
US6133002A (en) | 1997-09-25 | 2000-10-17 | Dsm N.V. | Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives |
US6340752B1 (en) * | 1998-01-06 | 2002-01-22 | Bristol-Myers Squibb Co. | Deprotection and recrystallization processes |
IT1298268B1 (it) * | 1998-02-18 | 1999-12-20 | Zambon Spa | Procedimento per la preparazione dell'acido (s)-2-bromo-3-fenil- propionico |
IT1298267B1 (it) * | 1998-02-18 | 1999-12-20 | Zambon Spa | Procedimento per la preparazione dell'acido (s)-2-acetiltio-3-fenil- propionico e dei suoi sali |
JP4588877B2 (ja) | 1998-06-17 | 2010-12-01 | ブリストル−マイヤーズ スクイブ カンパニー | Adp−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防 |
EP0965592A1 (en) | 1998-06-18 | 1999-12-22 | F. Hoffmann-La Roche Ag | Process for preparing 3-arylsulfur hydroxamic acids |
US6174711B1 (en) | 1998-07-05 | 2001-01-16 | Mitsubishi Gas Chemical Company | Method for producing L-allysine acetal |
US6162913A (en) * | 1998-07-15 | 2000-12-19 | Bristol-Myers Squibb Co. | Preparation of [4S-(4α,7α,10aβ)]-4-amino-octahydro-5-oxo-7H-pyrido[2,1 -b] [1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides |
EP1097236A4 (en) * | 1998-07-15 | 2006-10-04 | Bristol Myers Squibb Co | STEREOSELECTIVE REDUCING AMINATION OF KETONES |
IL140861A (en) * | 1998-07-15 | 2004-06-01 | Bristol Myers Squibb Co | Dioxolane pentanoic acid and processes for the preparation thereof |
US6468781B1 (en) | 1999-07-08 | 2002-10-22 | Bristol-Myers Squibb Company | Stereoselective reductive amination of ketones |
WO2000014265A1 (en) | 1998-09-03 | 2000-03-16 | Bristol-Myers Squibb Co. | Enzymatic oxidative deamination process |
EP1457478B1 (en) | 1998-11-11 | 2017-07-19 | Novartis AG | Production of 2-amino-2-[2-(4-alkyl-phenyl)ethyl]propane-1,3-diols |
KR20020002487A (ko) * | 1999-03-29 | 2002-01-09 | 스티븐 비. 데이비스 | 협심증 치료를 위한 바소펩티다제 억제제의 용도 |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
HUP0203326A3 (en) * | 1999-08-30 | 2003-04-28 | Sanofi Aventis Deutschland | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
US6300503B1 (en) * | 1999-12-17 | 2001-10-09 | Dixie Chemical Company | Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same |
NL1014354C2 (nl) * | 2000-02-11 | 2001-08-14 | Dsm Nv | Werkwijze voor de bereiding van (S) -2-acethylthio-3-fenylpropaanzuur. |
NL1014353C2 (nl) * | 2000-02-11 | 2001-08-15 | Dsm Nv | Werkwijze voor de bereiding van (R) -2-broom-3-fenylpropaanzuur. |
US6509330B2 (en) | 2000-02-17 | 2003-01-21 | Bristol-Myers Squibb Company | Hydroxamic acid containing compounds useful as ACE inhibitors and/or NEP inhibotors |
ES2227069T3 (es) | 2000-03-30 | 2005-04-01 | Ajinomoto Co., Inc. | Metodo de produccion de un derivado de acido acetiltiocarboxilico aromatico. |
US6620600B2 (en) | 2000-09-15 | 2003-09-16 | Bristol-Myers Squibb Co. | Enzymatic resolution of aryl and thio-substituted acids |
ATE309977T1 (de) | 2000-09-29 | 2005-12-15 | Bristol Myers Squibb Co | Dynamische trennung von isomeren und getrennte isomere |
US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
US6828119B2 (en) * | 2001-01-04 | 2004-12-07 | Bristol Myers Squibb Company | Enzymatic deprotection of amines and hydroxides |
US7119188B2 (en) * | 2001-01-04 | 2006-10-10 | Bristol-Myers Squibb Company | N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor |
AU2002365132A1 (en) * | 2001-10-17 | 2003-07-15 | Bristol-Myers Squibb Company | BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-Alpha CONVERTING ENZYME (TACE) |
US7107198B2 (en) * | 2001-11-02 | 2006-09-12 | Sun Microsystems, Inc. | Automatic generation of reduced-size circuit models including inductive interaction |
US6984645B2 (en) | 2001-11-16 | 2006-01-10 | Bristol-Myers Squibb Company | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
EP1463510A2 (en) * | 2001-12-20 | 2004-10-06 | Bristol-Myers Squibb Company | Administration of vasopeptidase inhibitors to reduce pulse pressure |
WO2003057200A2 (en) * | 2002-01-11 | 2003-07-17 | Novo Nordisk A/S | Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
US20070197552A1 (en) * | 2002-01-11 | 2007-08-23 | Novo Nordisk A/S | Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
EP1383042B1 (en) * | 2002-07-19 | 2007-03-28 | STMicroelectronics S.r.l. | A multiphase synchronous pipeline structure |
US6842358B2 (en) * | 2002-08-01 | 2005-01-11 | Netlogic Microsystems, Inc. | Content addressable memory with cascaded array |
US7045653B2 (en) * | 2002-12-23 | 2006-05-16 | Pfizer, Inc. | Pharmaceuticals |
CL2004000544A1 (es) * | 2003-03-18 | 2005-01-28 | Pharmacia Corp Sa Organizada B | Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati |
US7459474B2 (en) | 2003-06-11 | 2008-12-02 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
US20050054731A1 (en) * | 2003-09-08 | 2005-03-10 | Franco Folli | Multi-system therapy for diabetes, the metabolic syndrome and obesity |
US7371759B2 (en) | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
US7420059B2 (en) | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
GB0327839D0 (en) | 2003-12-01 | 2003-12-31 | Novartis Ag | Organic compounds |
US7273881B2 (en) | 2004-01-16 | 2007-09-25 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
NZ549535A (en) | 2004-03-17 | 2010-11-26 | Novartis Ag | Use of aliskiren for treating renal and other disorders |
US7888381B2 (en) | 2005-06-14 | 2011-02-15 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof |
EP1906934A4 (en) * | 2005-07-14 | 2012-03-07 | Franco Folli | DAILY DOSAGE SCHEME FOR THE TREATMENT OF DIABETES, OBESITY, METABOLIC SYNDROME AND POLYKYSTIC OVAIRE SYNDROME |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7390789B2 (en) * | 2005-09-13 | 2008-06-24 | William H Simmons | Thio-containing inhibitors of aminopeptidase P, and compositions thereof |
US7400236B2 (en) | 2005-10-21 | 2008-07-15 | Gm Global Technology Operations, Inc. | Vehicular lane monitoring system utilizing front and rear cameras |
US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US8202902B2 (en) | 2006-05-05 | 2012-06-19 | The Regents Of The University Of Michigan | Bivalent SMAC mimetics and the uses thereof |
AU2007248473B2 (en) * | 2006-05-05 | 2011-01-27 | The Regents Of The University Of Michigan | Bivalent Smac mimetics and the uses thereof |
US7795291B2 (en) | 2006-07-07 | 2010-09-14 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method |
JP5042311B2 (ja) | 2006-07-20 | 2012-10-03 | ノバルティス アーゲー | Cetp阻害剤としてのアミノピペリジン誘導体 |
JP2010508358A (ja) | 2006-11-01 | 2010-03-18 | ブリストル−マイヤーズ スクイブ カンパニー | グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用 |
EP2089355A2 (en) | 2006-11-01 | 2009-08-19 | Brystol-Myers Squibb Company | Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof |
WO2008057855A2 (en) | 2006-11-01 | 2008-05-15 | Bristol-Myers Squibb Company | Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
TW200838501A (en) * | 2007-02-02 | 2008-10-01 | Theravance Inc | Dual-acting antihypertensive agents |
TWI448284B (zh) | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2688161C (en) | 2007-06-04 | 2020-10-20 | Kunwar Shailubhai | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
TWI406850B (zh) * | 2007-06-05 | 2013-09-01 | Theravance Inc | 雙效苯并咪唑抗高血壓劑 |
JP2010538071A (ja) | 2007-09-07 | 2010-12-09 | セラヴァンス, インコーポレーテッド | 二重作用性降圧剤 |
PE20090982A1 (es) | 2007-11-05 | 2009-08-13 | Novartis Ag | Derivados de piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp) |
EP2229356B1 (en) | 2007-12-03 | 2011-10-12 | Novartis AG | 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
US20110015158A1 (en) | 2007-12-11 | 2011-01-20 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
EP2225210B1 (en) | 2007-12-11 | 2012-04-25 | Theravance, Inc. | Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
EP2297113A1 (en) | 2008-04-29 | 2011-03-23 | Theravance, Inc. | Dual-acting antihypertensive agents |
ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
EP2334671A1 (en) | 2008-06-24 | 2011-06-22 | Bristol-Myers Squibb Company | Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
JP2011529072A (ja) | 2008-07-24 | 2011-12-01 | セラヴァンス, インコーポレーテッド | 二重作用血圧降下薬 |
KR20120036850A (ko) | 2009-05-15 | 2012-04-18 | 노파르티스 아게 | 알도스테론 신타제 억제제로서의 벤족사졸론 유도체 |
MA33358B1 (fr) | 2009-05-15 | 2012-06-01 | Novartis Ag | Arylpyridine en tant qu'inhibiteurs de l'aldostérone synthase |
US20100317593A1 (en) * | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | 2,3-dihydro-1h-indene compounds |
WO2011005674A1 (en) | 2009-07-07 | 2011-01-13 | Theravance, Inc. | Dual-acting pyrazole antihypertensive agents |
WO2011011232A1 (en) | 2009-07-22 | 2011-01-27 | Theravance, Inc. | Dual-acting oxazole antihypertensive agents |
JP5654608B2 (ja) | 2009-11-17 | 2015-01-14 | ノバルティス アーゲー | アルドステロンシンターゼ阻害剤としてのアリール−ピリジン誘導体 |
WO2011064376A1 (en) | 2009-11-30 | 2011-06-03 | Novartis Ag | Imidazole derivatives as aldosterone synthase inhibitors |
WO2011090929A1 (en) | 2010-01-19 | 2011-07-28 | Theravance, Inc. | Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
WO2011116115A1 (en) | 2010-03-16 | 2011-09-22 | Novartis Ag | Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
US8993631B2 (en) | 2010-11-16 | 2015-03-31 | Novartis Ag | Method of treating contrast-induced nephropathy |
CA2817368C (en) | 2010-12-15 | 2019-12-31 | Theravance, Inc. | Neprilysin inhibitors |
EP2651900B1 (en) | 2010-12-15 | 2015-08-19 | Theravance Biopharma R&D IP, LLC | Neprilysin inhibitors |
JP5959066B2 (ja) | 2011-02-17 | 2016-08-02 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | ネプリライシン阻害剤としての置換アミノ酪酸誘導体 |
JP5959065B2 (ja) | 2011-02-17 | 2016-08-02 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | ネプリライシン阻害剤としての置換アミノ酪酸誘導体 |
WO2012166390A1 (en) | 2011-05-31 | 2012-12-06 | Theravance, Inc. | Neprilysin inhibitors |
CN103748070B (zh) | 2011-05-31 | 2015-06-24 | 施万生物制药研发Ip有限责任公司 | 脑啡肽酶抑制剂 |
CA2835216A1 (en) | 2011-05-31 | 2012-12-06 | Theravance, Inc. | Neprilysin inhibitors |
TWI560172B (en) | 2011-11-02 | 2016-12-01 | Theravance Biopharma R&D Ip Llc | Neprilysin inhibitors |
WO2013181332A1 (en) | 2012-05-31 | 2013-12-05 | Theravance, Inc. | Nitric oxide donor neprilysin inhibitors |
EP2858650B1 (en) | 2012-06-08 | 2018-11-14 | Theravance Biopharma R&D IP, LLC | Neprilysin inhibitors |
WO2013184934A1 (en) | 2012-06-08 | 2013-12-12 | Theravance, Inc. | Neprilysin inhibitors |
SI2882716T1 (sl) | 2012-08-08 | 2017-04-26 | Theravance Biopharma R&D Ip, Llc | Zaviralci neprilizina |
JP6382831B2 (ja) | 2012-11-30 | 2018-08-29 | サンフォード−バーンハム メディカル リサーチ インスティテュート | アポトーシス阻害タンパク質(iap)のアンタゴニスト |
US8901169B2 (en) | 2013-03-05 | 2014-12-02 | Theravance Biopharma R&D Ip, Llc | Neprilysin inhibitors |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
WO2015027021A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
ES2718239T3 (es) | 2014-01-30 | 2019-06-28 | Theravance Biopharma R&D Ip Llc | Inhibidores de neprilisina |
EP3099668B1 (en) | 2014-01-30 | 2022-05-04 | Theravance Biopharma R&D IP, LLC | 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors |
JP6729963B2 (ja) | 2014-01-31 | 2020-07-29 | 株式会社エーピーアイ コーポレーション | ピペコリン酸4位水酸化酵素およびそれを利用した4−ヒドロキシアミノ酸の製造法 |
EP3151920A4 (en) | 2014-06-04 | 2017-12-27 | Sanford-Burnham Medical Research Institute | Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy |
US9212206B1 (en) | 2014-11-24 | 2015-12-15 | William H Simmons | 4-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use |
MY187899A (en) | 2015-02-11 | 2021-10-27 | Theravance Biopharma R&D Ip Llc | (2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor |
RU2715241C2 (ru) | 2015-02-19 | 2020-02-26 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | (2r,4r)-5-(5′-хлор-2′-фторбифенил-4-ил)-2-гидрокси-4-[(5-метилоксазол-2-карбонил)амино]пентановая кислота |
RU2756223C2 (ru) | 2016-03-08 | 2021-09-28 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Кристаллическая (2s,4r)-5-(5'-хлор-2'-фтор-[1,1'-бифенил]-4-ил)-2-(этоксиметил)-4-(3-гидроксиизоксазол-5-карбоксамидо)-2-метилпентановая кислота и ее применения |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT20991B (de) | 1903-12-22 | 1905-08-10 | Duplex Radiator Company | Heizkörper für Gas- und Petroleumöfen. |
AT198791B (de) | 1950-12-20 | 1958-07-25 | Westinghouse Air Brake Co | Steuerventil für Druckluftbremsen von Schienenfahrzeugen |
DE2210633C2 (de) * | 1972-03-06 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
BG17877A1 (fi) * | 1972-09-26 | 1974-03-05 | ||
FR2265355B1 (fi) * | 1974-03-28 | 1977-11-04 | Blum Jean | |
US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4339600A (en) * | 1976-05-10 | 1982-07-13 | E. R. Squibb & Sons, Inc. | Compounds for alleviating angiotensin related hypertension |
FR2358891A1 (fr) * | 1976-07-22 | 1978-02-17 | Yamanouchi Pharma Co Ltd | Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires |
US4225495A (en) * | 1978-12-07 | 1980-09-30 | E. R. Squibb & Sons, Inc. | Pyrrolo or pyrido [2,1-c][1,4] thiazines or thiazepines |
US4192945A (en) * | 1978-12-07 | 1980-03-11 | E. R. Squibb & Sons, Inc. | Process for preparing proline and homoproline derivatives |
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
IL61972A0 (en) * | 1980-01-30 | 1981-02-27 | Beecham Group Ltd | Azabicyclic compounds,their preparation and pharmaceutical compositions containing them |
US4337201A (en) * | 1980-12-04 | 1982-06-29 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl substituted prolines |
US4415496A (en) * | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
US4432972A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4432971A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4873235A (en) * | 1982-06-01 | 1989-10-10 | Merck & Co., Inc. | Benzofused lactams as antihypertensives |
FR2540495B1 (fr) * | 1983-02-07 | 1986-02-14 | Roussel Uclaf | Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus |
US4711884A (en) * | 1983-02-28 | 1987-12-08 | E. R. Squibb & Sons, Inc. | Thiazine and thiazepine containing compounds |
US4460579A (en) * | 1983-02-28 | 1984-07-17 | E. R. Squibb & Sons, Inc. | Thiazine and thiazepine containing compounds |
US4617301A (en) * | 1983-06-22 | 1986-10-14 | Merck & Co., Inc. | Sulfoxide and sulfone derivatives of bicyclic lactams as antihypertensives |
US4722810A (en) * | 1984-08-16 | 1988-02-02 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4584294A (en) * | 1984-11-07 | 1986-04-22 | Merck & Co., Inc. | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
US4801609B1 (en) * | 1987-03-27 | 1993-11-09 | Mercapto-acylamino acid antihypertensives | |
EP0254032A3 (en) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
US4749688A (en) * | 1986-06-20 | 1988-06-07 | Schering Corporation | Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension |
CA1334092C (en) | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
CA1337400C (en) * | 1987-06-08 | 1995-10-24 | Norma G. Delaney | Inhibitors of neutral endopeptidase |
CA1338238C (en) | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
US4879309A (en) * | 1988-09-27 | 1989-11-07 | Schering Corporation | Mercapto-acylamino acids as antihypertensives |
US5075302A (en) * | 1990-03-09 | 1991-12-24 | Schering Corporation | Mercaptoacyl aminolactam endopeptidase inhibitors |
FR2664269B1 (fr) * | 1990-07-05 | 1992-10-02 | Roussel Uclaf | Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant. |
CA2053340C (en) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US5232920A (en) * | 1990-12-21 | 1993-08-03 | Schering Corporation | N-(mercaptoalkyl)amides |
FR2679564A1 (fr) * | 1991-07-23 | 1993-01-29 | Inst Nat Sante Rech Med | Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent. |
AU657793B2 (en) * | 1991-09-27 | 1995-03-23 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
CA2078758C (en) * | 1991-09-27 | 2003-12-09 | Alan M. Warshawsky | 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
CA2078759C (en) * | 1991-09-27 | 2003-09-16 | Alan M. Warshawsky | Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
KR100276029B1 (ko) * | 1992-02-14 | 2000-12-15 | 슈테펜엘.네스비트 | 아미노아세틸 머캅토아세틸 아미드 유도체 및 이의 제조방법 |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
JPH07508740A (ja) | 1992-07-10 | 1995-09-28 | ザ ブーツ カンパニー ピーエルシー | アンギオテンシン11アンタゴニストとしてのジオキソシクロブテン誘導体 |
ATE184604T1 (de) * | 1992-08-24 | 1999-10-15 | Merrell Pharma Inc | Neue 2-substituierte tricyclische derivate von indan-2-mercaptoacetylamid verwendbar als enkephalinase inhibitoren |
US5208236A (en) * | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
US5504080A (en) * | 1992-10-28 | 1996-04-02 | Bristol-Myers Squibb Co. | Benzo-fused lactams |
PT669936E (pt) * | 1992-10-30 | 2001-04-30 | Merrell Pharma Inc | Derivados de lactama biciclica de mercaptoacetilamida uteis como inibidores de encefalinase e de ace |
GB9302331D0 (en) * | 1993-02-05 | 1993-03-24 | Smithkline Beecham Plc | Process |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
US5362727A (en) * | 1993-07-26 | 1994-11-08 | Bristol-Myers Squibb | Substituted azepino[2,1-a]isoquinoline compounds |
US5525723A (en) * | 1993-11-18 | 1996-06-11 | Bristol-Myers Squibb Co. | Compounds containing a fused multiple ring lactam |
-
1994
- 1994-05-05 US US08/238,764 patent/US5508272A/en not_active Expired - Lifetime
- 1994-05-17 TW TW083104449A patent/TW329423B/zh not_active IP Right Cessation
- 1994-05-26 CA CA002124375A patent/CA2124375C/en not_active Expired - Fee Related
- 1994-06-01 UA UA94005237A patent/UA39924C2/uk unknown
- 1994-06-07 IL IL10992494A patent/IL109924A/en not_active IP Right Cessation
- 1994-06-08 GE GEAP19941983A patent/GEP19981301B/en unknown
- 1994-06-08 CZ CZ19941402A patent/CZ289488B6/cs not_active IP Right Cessation
- 1994-06-10 CN CN94106426A patent/CN1046525C/zh not_active Expired - Fee Related
- 1994-06-10 MY MYPI94001478A patent/MY123673A/en unknown
- 1994-06-10 JP JP12870694A patent/JP3569550B2/ja not_active Expired - Fee Related
- 1994-06-13 NZ NZ260736A patent/NZ260736A/en not_active IP Right Cessation
- 1994-06-13 EP EP94304266A patent/EP0629627B1/en not_active Expired - Lifetime
- 1994-06-13 FI FI942793A patent/FI106464B/fi active
- 1994-06-13 ZA ZA944163A patent/ZA944163B/xx unknown
- 1994-06-13 DE DE69433752T patent/DE69433752T2/de not_active Expired - Fee Related
- 1994-06-13 DK DK94304266T patent/DK0629627T3/da active
- 1994-06-13 ES ES94304266T patent/ES2219644T3/es not_active Expired - Lifetime
- 1994-06-13 PT PT94304266T patent/PT629627E/pt unknown
- 1994-06-13 AT AT94304266T patent/ATE266032T1/de not_active IP Right Cessation
- 1994-06-13 SG SG1996005366A patent/SG46510A1/en unknown
- 1994-06-13 NO NO942208A patent/NO306405B1/no unknown
- 1994-06-14 KR KR1019940013316A patent/KR100395604B1/ko not_active IP Right Cessation
- 1994-06-14 BG BG98854A patent/BG62139B1/bg unknown
- 1994-06-14 EG EG35294A patent/EG20537A/xx active
- 1994-06-14 RO RO94-01020A patent/RO112870B1/ro unknown
- 1994-06-14 SK SK725-94A patent/SK282529B6/sk not_active IP Right Cessation
- 1994-06-14 HU HU9401776A patent/HU216791B/hu not_active IP Right Cessation
- 1994-06-14 LV LVP-94-122A patent/LV10622B/xx unknown
- 1994-06-14 PH PH48437A patent/PH30830A/en unknown
- 1994-06-14 RU RU94021350A patent/RU2125056C1/ru not_active IP Right Cessation
- 1994-06-14 AU AU64667/94A patent/AU672899B2/en not_active Ceased
- 1994-06-14 PL PL94303832A patent/PL178469B1/pl not_active IP Right Cessation
- 1994-06-14 LT LTIP1954A patent/LT3626B/lt not_active IP Right Cessation
- 1994-06-15 UY UY23787A patent/UY23787A1/es not_active IP Right Cessation
- 1994-10-31 EE EE9400106A patent/EE03178B1/xx not_active IP Right Cessation
-
1995
- 1995-11-22 US US08/562,324 patent/US5672599A/en not_active Expired - Lifetime
-
1996
- 1996-01-04 US US08/582,798 patent/US5627278A/en not_active Expired - Fee Related
- 1996-01-17 US US08/588,037 patent/US5670699A/en not_active Expired - Fee Related
-
1997
- 1997-01-22 IL IL12005197A patent/IL120051A0/xx unknown
- 1997-05-09 US US08/853,398 patent/US5756832A/en not_active Expired - Fee Related
- 1997-05-14 BR BR1100970-5A patent/BR1100970A/pt active IP Right Grant
-
1998
- 1998-01-27 HK HK98100738A patent/HK1001814A1/xx not_active IP Right Cessation
-
2000
- 2000-04-06 FI FI20000814A patent/FI111947B/fi active
- 2000-04-06 FI FI20000815A patent/FI111950B/fi active
-
2004
- 2004-10-06 CY CY0400073A patent/CY2492B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI942793A (fi) | Fuusioituneen bisyklisen renkaan sisältäviä yhdisteitä ja menetelmiä niiden valmistamiseksi | |
AU673111B2 (en) | Compounds containing a fused multiple ring lactam | |
ES2101960T3 (es) | Lactamas benzo-condensadas. | |
DK0997459T3 (da) | Mellemprodukter til fremstilling af retrovirale protease-hæmmere | |
DE69610873D1 (de) | Thiazolobenzazepin-enthaltende Inhibitoren mit zweifacher Wirkung | |
DK0747392T3 (da) | Dobbeltvirkende inhibitorer indeholdende 1,2-diazepiner | |
FI895185A0 (fi) | Mevalonolaktoner av tienopyridintyp. | |
DK0545511T3 (da) | Fremgangsmåde til fremstilling af mono-N-substiuerede tetraazamakrocycler | |
FI905664A0 (fi) | Glutarsyraderivat och deras framstaellningsfoerfaranden. |